tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196
Hong Kong Market

Shanghai Fosun Pharmaceutical (Group) Co (2196) Stock Forecast & Price Target

Compare
2 Followers
See the Price Targets and Ratings of:

2196 Financial Forecast

2196 Earnings Forecast

Next quarter’s earnings estimate for 2196 is HK$0.31 with a range of HK$0.28 to HK$0.35. The previous quarter’s EPS was HK$0.31. 2196 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.
Next quarter’s earnings estimate for 2196 is HK$0.31 with a range of HK$0.28 to HK$0.35. The previous quarter’s EPS was HK$0.31. 2196 beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.24% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.

2196 Sales Forecast

Next quarter’s sales forecast for 2196 is HK$10.65B with a range of HK$10.65B to HK$10.65B. The previous quarter’s sales results were ―. 2196 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.
Next quarter’s sales forecast for 2196 is HK$10.65B with a range of HK$10.65B to HK$10.65B. The previous quarter’s sales results were ―. 2196 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year 2196 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on HK:2196
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$14.2
Hold
-0.70%
Downside
Downgraded
01/17/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on HK:2196
Unknown AnalystMorgan Stanley
Not Ranked
Morgan Stanley
HK$14.2
Hold
-0.70%
Downside
Downgraded
01/17/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2196 Analyst Recommendation Trends

Rating
Oct 23
Jan 25
Strong Buy
0
0
Buy
0
0
Hold
1
2
Sell
0
0
Strong Sell
0
0
total
1
2
In the current month, 2196 has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 2196 average Analyst price target in the past 3 months is 14.20.
Each month's total comprises the sum of three months' worth of ratings.

2196 Stock Forecast FAQ

What is HK:2196’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s 12-month average price target is 14.20.
    What is HK:2196’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for HK:2196, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H a Buy, Sell or Hold?
        Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s share price target?
          The average share price target for Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H is 14.20. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is HK$14.20 ,and the lowest forecast is HK$14.20. The average share price target represents -0.67% Decrease from the current price of HK$14.3.
            What do analysts say about Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
            Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
              To buy shares of HK:2196, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis